Jean Melville
- Co-authors
- David P. LaneNikolai ZhelevPeter M. FischerDavid E. MacCallumAthos Gianella-BorradoriSian AndersonSheelagh FrameSimon R. Green
- Topics
- Cancer-related Molecular Pathways (4 papers)Advanced Breast Cancer Therapies (3 papers)Cancer Treatment and Pharmacology (3 papers)
- Partner nations
- United KingdomFrance
In The Last Decade
Jean Melville
9 papers receiving 745 citations
Peers
Comparison fields: 5 of 69
- Molecular Biology 497
- Oncology 373
- Cell Biology 129
- Pulmonary and Respiratory Medicine 124
- Genetics 73
Countries citing papers authored by Jean Melville
This map shows the geographic impact of Jean Melville's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean Melville with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean Melville more than expected).
Fields of papers citing papers by Jean Melville
This network shows the impact of papers produced by Jean Melville. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean Melville. The network helps show where Jean Melville may publish in the future.
Co-authorship network of co-authors of Jean Melville
This figure shows the co-authorship network connecting the top 25 collaborators of Jean Melville. A scholar is included among the top collaborators of Jean Melville based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean Melville. Jean Melville is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Novel cyclin dependent kinase (CDK) inhibitors induce down regulation of Mcl-1 and apoptosis in multiple myeloma cells | 1 |
| 2 | 245 | |
| 3 | CYC202 (R-Roscovitine) induces apoptosis in multiple myeloma cells by down regulation of Mcl-1 | 4 |
| 4 | 1 | |
| 5 | 3 | |
| 6 | 306 | |
| 7 | 144 | |
| 8 | 1 | |
| 9 | Lisinopril, an angiotensin I-converting enzyme inhibitor, prevents entry of murine hematopoietic stem cells into the cell cycle after irradiation in vivo. | 20 |
| 10 | 43 |
About Jean Melville
Jean Melville is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 10 papers that have together received 768 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (4 papers), Advanced Breast Cancer Therapies (3 papers) and Cancer Treatment and Pharmacology (3 papers). The work is most often cited by research in Oncology (373 citations), Cell Biology (129 citations) and Molecular Biology (497 citations). Jean Melville has collaborated with scholars based in United Kingdom and France. Frequent co-authors include David P. Lane, Nikolai Zhelev, Peter M. Fischer, David E. MacCallum, Athos Gianella-Borradori, Sian Anderson, Sheelagh Frame, Simon R. Green, Steven J. McClue and Rosemary G. Clarke. Their work appears in journals such as Cancer Research, International Journal of Cancer and Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.